Patent · US Active

Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

US9458153B2 · kind B2 · utility

19Cited by

0References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Xingchun Han · Shanghai, CN
Hassan Javanbakht · Basel, CH
Min Jiang · Lexington, US
Chungen Liang · Shanghai, CN
Jianping Wang · Västerås, SE
Yongguang Wang · Fujian, CN
Zhanguo Wang · Shanghai, CN
Robert James Weikert · Clifton, US
Song Yang · Shanghai, CN
Chengang Zhou · Shanghai, CN

Key dates

Filing date	Jan 30, 2015
Grant date	Oct 4, 2016
Priority date	—
Expiry date	Jan 30, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel compounds having the general formula:wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.